Back to Search
ALLISON BURDICK, PHARMD
PHARMD
Emergency Medicine Pharmacist
NPI: 1700518602Individual
Specialties, Licenses & Credentials
Research & Publications (20)
Type 1 leprosy reaction manifesting after discontinuation of adalimumab therapy.
PMID 19289788·Arch Dermatol·2009
5-case
Deep brain stimulation for refractory obsessive-compulsive disorder.
PMID 19273170·Front Biosci (Landmark Ed)·2009
6-review
American Telemedicine Association's Practice Guidelines for Teledermatology.
PMID 18570555·Telemed J E Health·2008
8-other
Deregulation of tumor angiogenesis and blockade of tumor growth in PPARbeta-deficient mice.
PMID 17641685·EMBO J·2007
7-preclinical
Ligand activation of peroxisome proliferator-activated receptor-beta/delta(PPARbeta/delta) inhibits cell growth of human N/TERT-1 keratinocytes.
PMID 17254750·Cell Signal·2007
7-preclinical
The toxicology of ligands for peroxisome proliferator-activated receptors (PPAR).
PMID 16322072·Toxicol Sci·2006
6-review
PYK2 mediates anti-apoptotic AKT signaling in response to benzo[a]pyrene diol epoxide in mammary epithelial cells.
PMID 16774943·Carcinogenesis·2006
8-other
The role of peroxisome proliferator-activated receptor-beta/delta in epithelial cell growth and differentiation.
PMID 16109478·Cell Signal·2006
6-review
The role of mycophenolate mofetil in the treatment of leprosy reactions.
PMID 16830656·Int J Lepr Other Mycobact Dis·2005
5-case
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Request Appointment
This provider isn't set up for online booking yet. Once you submit, we'll reach out to their office to arrange secure delivery of your request.
Contact & Hours
- Address
- 2101 ADELBERT RD
CLEVELAND, OH 44106 - Phone
- (216) 844-3911
Quick Facts
- NPI
- 1700518602
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile